1. P48 The effects of tgf-Β and il-33 on the pro-fibrotic activity of primary human lung fibroblasts during the development of ipf. (15th November 2017) Authors: Stephenson, KE; Overed-Sayer, CL; John, AE; Cohen, ES; Jenkins, RG Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis. (18th December 2012) Authors: Minter, RR; Cohen, ES; Wang, B; Liang, M; Vainshtein, I; Rees, G; Eghobamien, L; Harrison, P; Sims, DA; Matthews, C; Wilkinson, T; Monk, P; Drinkwater, C; Fabri, L; Nash, A; McCourt, M; Jermutus, L; Roskos, L; Anderson, IK; Sleeman, MA Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis. (18th December 2012) Authors: Minter, RR; Cohen, ES; Wang, B; Liang, M; Vainshtein, I; Rees, G; Eghobamien, L; Harrison, P; Sims, DA; Matthews, C; Wilkinson, T; Monk, P; Drinkwater, C; Fabri, L; Nash, A; McCourt, M; Jermutus, L; Roskos, L; Anderson, IK; Sleeman, MA Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗